Issue: ORN-2026-44
NJIT Research Newsletter includes recent awards, and announcements of research related seminars, webinars, national and federal research news related to research funding, and Grant Opportunity Alerts (with links to sections). The Newsletter is posted on the NJIT Research Website https://research.njit.edu/funding-opportunities.
Special Announcements
Center for Translational Research (CTR) 2026 Workshop on
Personalized, Predictive and Preventive Healthcare Innovations (P3HI)
HealthTech, Digital Health and AI Trends
For Full Program Announcement with Speakers’ Biographical Sketches: Click Here
Sponsored by
NSF ART (Accelerating Research Translation) Program at NJIT
National Academy of Inventors (NAI) – NJIT Chapter
Co-organizers and Co-Chairs
Atam P. Dhawan, Ph.D., Chief Strategic Innovation Officer, Senior Vice Provost for Research, NJIT; Executive Director – Center for Translational Research
Arunan Skandarajah, Ph.D., Founder and Principal, Nalam Ventures, Former Small Business Manager and Translational R&D and Commercialization Lead, Advanced Research Projects Agency for Health (ARPA-H)
Date and Venue: November 12, 2026, 8.00 AM – 4.45 PM; Atrium, Campus Center
Recent technological and pharmaceutical advances in healthcare have yielded tremendous improvements in the diagnosis and treatment of deadly maladies, from cardiac and brain disorders to cancers to infectious diseases. Yet a critical problem remains: the lack of “HealthTech” innovations available to all people for sustainable point-of-care, personalized monitoring towards preventive, predictive, and precision healthcare, understanding the onset and progression of pathological conditions, effective treatment and therapeutic intervention, and, more importantly, changing behavior to stay healthy in the long-term. Global healthcare, particularly in under-resourced communities in both impoverished and affluent nations, suffers from limited access to the life-changing remedies many of us take for granted. These disparities are unsustainable in a functioning global society.
In addition, the CTR 2026 P3HI Workshop will feature a Translational Research and Innovation Showcase with the participation of HealthTech researchers and technology leaders from healthcare stakeholder sectors, including academia, medical and clinical centers, industry, federal agencies, foundations, and communities. Personalized medicine is here, and interacting with these innovators will put a fine point on the challenges and opportunities.
_________________________________
ARPA-H Commercialization Services
Commercialization begins before research ends
The Advanced Research Projects Agency for Health (ARPA-H) funds impactful research and discovery that accelerates breakthrough technologies into the marketplace. Our goal is to deliver these benefits to patients, providers, and communities in years, not decades. The Office of Commercialization helps prepare successful innovations for transition, follow-on funding, or other partnerships so that the work can continue beyond the agency’s initial investment.
We serve Program Managers in their work with entrepreneurs, startups, academic institutions, investors, and industry partners to identify commercialization needs and challenges, strengthen transition strategies, and prepare innovations for adoption beyond the laboratory.
About the Office of Commercialization: Commercialization begins in program development and continues throughout the performance period. Every funded opportunity must answer the same questions.
Who needs it?
Who will adopt it?
Who will pay for it?
How will it reach the people it was designed to help?
These questions matter at every stage. They keep us focused on the people our investments are meant to serve – patients, providers, and communities that stand to benefit.
Our office brings together expertise from across the commercialization continuum including experts from the investment community, senior advisors in regulatory planning, reimbursement, and intellectual property, and staff versed in product development and commercialization readiness.
We work alongside Program Managers and performers conducting cutting-edge research to help them navigate decisions that determine whether an innovation becomes a product, a platform, or a company. Our role is to accelerate that critical path from discovery to impact.
Available Program Opportunities:
Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and Supplies (FASTPASS)
Simulation-augmented, real-time Platform Adaptive Seamless Trials (SURPASS)
Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)
Grant Opportunity Alerts
NSF: Major Research Instrumentation Program (MRI); Supplemental Funding Requests to Support Super Intelligence (SI) Innovation in the Presidential SI Challenge
NIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H): Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Department of War/US Army/DARPA/ONR: AFRL/AFOSR-Taiwan NSTC Frontiers in Materials and Nanostructures: AI-Driven Discovery, Quantum Geometry, and Energy-Efficient Information Technologies 2027-2030; Young Faculty Award (YFA) 2027
NIH: NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18)
Department of Energy: Grid Supply Chain Alternatives to Lead Energy Dominance (SCALED)
NASA: ROSES 2025: D.10 Astrophysics Theory
Recent Research Grant and Contract Awards
In the News
Tech policy coalition calls for new Congress to set AI safety standards: The Chamber of Progress, a center-left tech industry policy coalition, is calling on the 2027 Democratic Congress to establish federal artificial intelligence safety standards. In a Nov. 4 memo to House and Senate Democratic leadership, the Chamber of Progress laid out a technology to-do list for 2027, with an eye on delivering more consumer protection and access to technological benefits. The memo laid out 10 priorities, chief among them passing a federal AI transparency and safety standard.
“Democrats should establish a national AI framework combining public transparency, independent evaluation, and enforceable safeguards for the most capable models,” Koustubh KJ Bagchi, the group’s vice president of policy and government relations, wrote in the memo. Bagchi said Congress should require developers to publish safety frameworks, report critical incidents and protect whistleblowers. He pointed to the FRONTIER Act, which Reps. Jay Obernolte, R-Calif., and Lori Trahan, D-Mass., introduced in July, as a piece of legislation for Congress to build upon. That bill aims to establish a national framework governing the development and deployment of the most advanced AI models. More information is posted on the NextGov website.
_______________________________
Industry groups urge Congress to renew cyber threat-sharing law through defense authorization: A coalition of 35 industry groups is urging Congress to use the annual defense policy bill to renew a law that gives companies legal protections when they share information about cyber threats with the federal government. In a Nov. 1 letter to the leaders of the House and Senate Armed Services committees, the groups asked negotiators to keep a provision in the House bill that would extend the Cybersecurity Information Sharing Act of 2015 through 2035. The law lapsed during last year’s record government shutdown and has since stayed in place through a series of spending bills. Its current extension expires Dec. 11. The signers include the U.S. Chamber of Commerce, Business Software Alliance, American Bankers Association, Airlines for America, the American Public Power Association and the National Rural Water Association. More information is posted on the NextGov website.
Webinars and Events
Research Grant Opportunities:
National Science Foundation
Air Force Office of Scientific Research
DARPA
ARPA-H
National Institutes of Health
Department of Energy
NASA
Proposal Submission and Streamlyne Information
The NJIT Proposal Submission Guidelines and Policy provides the expected institutional timeline for proposal submission. Streamlyne User Manuals are posted on https://research.njit.edu/streamlyne. For contact information on proposal submission, pre-award services and post-award grant management, please visit research website https://research.njit.edu/researchers and https://research.njit.edu/contact.